Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Pooled RR showed that vitamin D supplementation did not reduce cancer mortality risk (RR 0.96, 95% CI: 0.80 to 1.16, I2 = 58%; Figure 2A).

Source: 3.2. Cancer Mortality. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Systematic review.

Systematic review

Uses explicit methods to identify, assess and summarise research on a defined question.

Meta-analysis reported · Blinding not applicable to this review · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Association between Vitamin D Supplementation and Cancer Mortality: A Systematic Review and Meta-Analysis

Source: Article title.

Association between Vitamin D Supplementation and Cancer Mortality: A Systematic Review and Meta-Analysis

Source: Article title.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Association between Vitamin D Supplementation and Cancer Mortality: A Systematic Review and Meta-Analysis

Systematic review · Cancers · 2022

Original publication title

Association between Vitamin D Supplementation and Cancer Mortality: A Systematic Review and Meta-Analysis

Renjie Zhang; Yu Zhang; Zheran Liu; Yiyan Pei; Ping Xu; Weelic Chong; Yang Hai; Ling He; Yan He; Jiayi Yu; Jingjing Wang; Fang Fang; Xingchen Peng

© 2022 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

Abstract: Simple Summary

It has been questioned whether vitamin D supplements can reduce the mortality and incidence of tumors. In this systematic review and meta-analysis of 12 randomized controlled trials with a total of 72,669 participants, vitamin D supplementation could not reduce the cancer mortality or cancer incidence. Our results suggest a reconsideration of the previous view that vitamin D supplementation could reduce overall cancer mortality is needed.

Source: Simple Summary

Abstract: Abstract

Background: Vitamin D deficiency is related to increased cancer risk and deaths. However, whether vitamin D supplementation reduces cancer mortality remains unclear, and several randomized controlled trials yield inconsistent results. Methods: Medline, Embase, and the Cochrane Central Register of Controlled Trials were searched from their inception until 28 June 2022, for randomized controlled trials investigating vitamin D supplementation. Pooled relative risks (RRs) and their 95% confidence intervals (CIs) were estimated. Trials with vitamin D supplementation combined with calcium supplementation versus placebo alone and recruiting participants with cancer at baseline were excluded in the present study.

Results: This study included 12 trials with a total of 72,669 participants. Vitamin D supplementation did not reduce overall cancer mortality (RR 0.96, 95% CI 0.80 to 1.16). However, vitamin D supplementation was associated with a reduction in lung cancer mortality (RR 0.63, 95% CI 0.45 to 0.90). Conclusions: Vitamin D supplementation could not reduce cancer mortality in this highly purified meta-analysis. Further RCTs that evaluate the association between vitamin D supplementation and total cancer mortality are still needed.

Source: Abstract
Authors’ abstract

Simple Summary

It has been questioned whether vitamin D supplements can reduce the mortality and incidence of tumors. In this systematic review and meta-analysis of 12 randomized controlled trials with a total of 72,669 participants, vitamin D supplementation could not reduce the cancer mortality or cancer incidence. Our results suggest a reconsideration of the previous view that vitamin D supplementation could reduce overall cancer mortality is needed.

Abstract

Background: Vitamin D deficiency is related to increased cancer risk and deaths. However, whether vitamin D supplementation reduces cancer mortality remains unclear, and several randomized controlled trials yield inconsistent results. Methods: Medline, Embase, and the Cochrane Central Register of Controlled Trials were searched from their inception until 28 June 2022, for randomized controlled trials investigating vitamin D supplementation. Pooled relative risks (RRs) and their 95% confidence intervals (CIs) were estimated. Trials with vitamin D supplementation combined with calcium supplementation versus placebo alone and recruiting participants with cancer at baseline were excluded in the present study.

Results: This study included 12 trials with a total of 72,669 participants. Vitamin D supplementation did not reduce overall cancer mortality (RR 0.96, 95% CI 0.80 to 1.16). However, vitamin D supplementation was associated with a reduction in lung cancer mortality (RR 0.63, 95% CI 0.45 to 0.90). Conclusions: Vitamin D supplementation could not reduce cancer mortality in this highly purified meta-analysis. Further RCTs that evaluate the association between vitamin D supplementation and total cancer mortality are still needed.

Publication and source details

Original title: Association between Vitamin D Supplementation and Cancer Mortality: A Systematic Review and Meta-Analysis

Renjie Zhang; Yu Zhang; Zheran Liu; Yiyan Pei; Ping Xu; Weelic Chong; Yang Hai; Ling He; Yan He; Jiayi Yu; Jingjing Wang; Fang Fang; Xingchen Peng

Cancers · 2022

* Correspondence: pxx2014@scu.edu.cn
†

These authors contributed equally to this work.

© 2022 by the authors.2022https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).National Natural Science Foundation of China821728428180310481672386Sichuan Province Science and Technology Support Program2021YFSY0082020YFS0276West China Nursing Discipline Development Special Fund ProjectHXHL21008Technology Innovation Project of Chengdu Science and Technology Bureau2019-YF05-00459-SNPostdoctoral research and Development Fund and Translational medicine fund of West China Hospital2020HXBH119CGZH19002National Key R&D Program of China2018YFA0108604the 1·3·5 project for disciplines of excellence-Clinical Research Incubation Project, West China Hospital, Sichuan University21HXFH046Affiliated Hospital of Clinical Medicine College of Chengdu UniversityCDFYCX202203Sichuan Science and Technology Bureau22ZDYF0798Clinical Incubation Program of West China Hospital, SCU2018HXFU008The work was supported by National Natural Science Foundation of China (Grant Nos. 82172842, and 81803104 and 81672386), the Sichuan Province Science and Technology Support Program (Grant Nos. 2021YFSY008, 2020YFS0276), West China Nursing Discipline Development Special Fund Project (Grant No. HXHL21008), the Technology Innovation Project of Chengdu Science and Technology Bureau (Grant No. 2019-YF05-00459-SN), Postdoctoral research and Development Fund and Translational medicine fund of West China Hospital (Grant Nos. 2020HXBH119 and CGZH19002, National Key R&D Program of China (2018YFA0108604), the 1·3·5 project for disciplines of excellence-Clinical Research Incubation Project, West China Hospital, Sichuan University (21HXFH046), the innovation team project of Affiliated Hospital of Clinical Medicine College of Chengdu University (CDFYCX202203), the project of Sichuan Science and Technology Bureau (22ZDYF0798), and Clinical Incubation Program of West China Hospital, SCU (2018HXFU008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T09:14:35.270991+00:00

DOI: 10.3390/cancers14153717 · PMC9367315